Rapport Therapeutics, Inc.
RAPP
$27.62
-$0.22-0.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.38% | 96.98% | -8.74% | -6.52% | -4.80% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.84% | -22.31% | 9,590.00% | -97.74% | 390.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 95.24% | 0.00% | -98.09% | 5,124.76% | -97.60% |
| Total Current Assets | -4.24% | 92.66% | -7.12% | -6.08% | -4.95% |
|
|
|||||
| Total Current Assets | -4.24% | 92.66% | -7.12% | -6.08% | -4.95% |
| Net Property, Plant & Equipment | -5.23% | -4.38% | 30.76% | 118.75% | -0.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.77% | 3.29% | 390.05% | 31.88% | -15.34% |
| Total Assets | -4.28% | 87.51% | -5.48% | -4.09% | -4.90% |
|
|
|||||
| Total Accounts Payable | 29.52% | 1.86% | 48.48% | 9.47% | 47.69% |
| Total Accrued Expenses | 40.76% | 23.83% | 11.35% | 2.63% | 20.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.00% | 41.10% | 74.50% | 36.77% | 2.36% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.06% | 20.52% | 26.60% | 7.03% | 23.50% |
|
|
|||||
| Total Current Liabilities | 33.06% | 20.52% | 26.60% | 7.03% | 23.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.04% | -7.07% | 47.85% | 824.76% | -20.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.18% | 7.84% | 35.56% | 70.60% | 18.38% |
|
|
|||||
| Common Stock & APIC | 0.90% | 62.72% | 1.01% | 0.94% | 0.75% |
| Retained Earnings | -16.76% | -15.43% | -18.09% | -19.45% | -19.26% |
| Treasury Stock & Other | 276.55% | 290.79% | 20.00% | 81.80% | -230.50% |
| Total Common Equity | -5.27% | 94.15% | -7.81% | -6.41% | -5.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.27% | 94.15% | -7.81% | -6.41% | -5.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.27% | 94.15% | -7.81% | -6.41% | -5.47% |
|
|
|||||